Trial intelligence / Profile preview

Preventive Effect of 5% Lidocaine Plaster on Neuropathic Pain After Osteoporotic Vertebral Fracture

NCT07691359Phase 4Not yet recruiting

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Jul 2026
Primary completion
Oct 2027
Countries
1
01

Overview

A Phase 4 trial of lidocaine 10% oropharyngeal spray in neuropathic pain, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT07691359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07691359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call